Literature DB >> 1968084

CD8 is required during positive selection of CD4-/CD8+ T cells.

J C Zúñiga-Pflücker1, L A Jones, D L Longo, A M Kruisbeek.   

Abstract

Interactions between self-MHC molecules and T cells are necessary for the proper development of mature T cells, in part due to an absolute requirement for self-MHC-TCR interactions. Recently, we showed that CD4-mediated interactions also participate in shaping the T cell repertoire during thymic maturation. We now examine the possible role of the CD8 molecule during in vivo T cell development. Our results demonstrate that perinatal thymi treated with intact anti-CD8 mAb fail to generate CD8 single-positive T cells, while the generation of the other main phenotypes remains unchanged. Most importantly, the use of F(ab')2 anti-CD8 mAb fragments gave identical results, i.e., lack of generation of CD4-/CD8+ cells, with no effect on the generation of CD4+/CD8+. Furthermore, selective blocking of one CD8 allele with F(ab')2 mAbs in F1 mice expressing both CD8 alleles did not interfere with the development of CD4-/CD8+ cells, demonstrating that the absence of CD8+ T cells in homozygous mice is not due to depletion, but rather is caused by a lack of positive selection. This is most likely attributable to a deficient CD8-MHC class I interaction. Our findings strongly advocate that CD8 molecules are vital to the selection process that leads to the development of mature single-positive CD8 T cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968084      PMCID: PMC2187717          DOI: 10.1084/jem.171.2.427

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

Review 1.  T-cell antigen receptor genes and T-cell recognition.

Authors:  M M Davis; P J Bjorkman
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

2.  Phosphorylation of CD4 and CD8 molecules following T cell triggering.

Authors:  M L Blue; D A Hafler; K A Craig; H Levine; S F Schlossman
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

3.  The development of helper T cell precursors in mouse thymus.

Authors:  P Marrack; E Kushnir; W Born; M McDuffie; J Kappler
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

4.  Deletion of self-reactive thymocytes occurs at a CD4+8+ precursor stage.

Authors:  B J Fowlkes; R H Schwartz; D M Pardoll
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

5.  T-cell development. Accessories or coreceptors?

Authors:  C A Janeway
Journal:  Nature       Date:  1988-09-15       Impact factor: 49.962

6.  A regulatory role for the CD4 and CD8 molecules in T cell activation.

Authors:  H Schrezenmeier; B Fleischer
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

7.  Intrathymic deletion of self-reactive cells prevented by neonatal anti-CD4 antibody treatment.

Authors:  H R MacDonald; H Hengartner; T Pedrazzini
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

8.  Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4/CD8 phenotype of T cells.

Authors:  H S Teh; P Kisielow; B Scott; H Kishi; Y Uematsu; H Blüthmann; H von Boehmer
Journal:  Nature       Date:  1988-09-15       Impact factor: 49.962

9.  The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck.

Authors:  A Veillette; M A Bookman; E M Horak; J B Bolen
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

10.  Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes.

Authors:  P Kisielow; H Blüthmann; U D Staerz; M Steinmetz; H von Boehmer
Journal:  Nature       Date:  1988-06-23       Impact factor: 49.962

View more
  21 in total

Review 1.  The role of CD4 in regulating homeostasis of T helper cells.

Authors:  Rolf König; Xiaoli Shen; Rosario Maroto; Timothy L Denning
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Unresponsiveness to Mlsa induced in newborn Mlsb mice by maternal preimmunization.

Authors:  A Matossian-Rogers; L DeGiorgi; L DeGiori
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

3.  Enhancement of CD3-mediated thymocyte apoptosis by the cross-linkage of heat-stable antigen.

Authors:  Y Hitsumoto; D S Song; M Okada; F Hamada; S Saheki; N Takeuchi
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

4.  Characterization of the mouse CD8 beta chain-encoding gene promoter region.

Authors:  Y Kawachi; F Otsuka; H Nakauchi
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

Review 5.  Potential targeting of B7-H4 for the treatment of cancer.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

6.  Phenotypic and functional analysis of positive selection in the gamma/delta T cell lineage.

Authors:  F B Wells; Y Tatsumi; J A Bluestone; S M Hedrick; J P Allison; L A Matis
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

7.  Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice.

Authors:  G Strauss; D A Vignali; G Schönrich; G J Hämmerling
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

8.  The role of charge and multiple faces of the CD8 alpha/alpha homodimer in binding to major histocompatibility complex class I molecules: support for a bivalent model.

Authors:  P A Giblin; D J Leahy; J Mennone; P B Kavathas
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

9.  Identification and characterization of an Alu-containing, T-cell-specific enhancer located in the last intron of the human CD8 alpha gene.

Authors:  J E Hambor; J Mennone; M E Coon; J H Hanke; P Kavathas
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

10.  Human CD4 restores normal T cell development and function in mice deficient in murine CD4.

Authors:  Y M Law; R S Yeung; C Mamalaki; D Kioussis; T W Mak; R A Flavell
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.